Literature DB >> 7818259

Elevated mast cell tryptase in cerebrospinal fluid of multiple sclerosis patients.

J J Rozniecki1, S L Hauser, M Stein, R Lincoln, T C Theoharides.   

Abstract

Multiple sclerosis (MS) lesions are associated with infiltration of T lymphocytes and macrophages that appear to mediate myelin destruction and gliosis (scarring). Mast cells are located perivascularly in the brain, are juxtaposed to neurons, and have been shown to secrete vasoactive and inflammatory mediators in response to neuropeptides and direct nerve stimulation. Mast cells have been previously identified in MS lesions, are activated by myelin basic protein, and can participate in the regulation of blood-brain barrier permeability, as well as in myelin destruction. Here, cerebrospinal fluid from MS patients and controls with other neurologic diseases was assayed for histamine, its major metabolite methylhistamine, and the specific mast cell marker tryptase. Histamine and methylhistamine were not elevated in MS. However, the mast cell specific proteolytic enzyme tryptase was significantly elevated in MS, suggesting that mast cell activation may be involved in the pathophysiology of this disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7818259     DOI: 10.1002/ana.410370112

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  62 in total

1.  Mast cells in the sheep, hedgehog and rat forebrain.

Authors:  H C Michaloudi; G C Papadopoulos
Journal:  J Anat       Date:  1999-11       Impact factor: 2.610

Review 2.  Ocular mast cells. Characterization in normal and disease states.

Authors:  E B Cook; J L Stahl; N P Barney; F M Graziano
Journal:  Clin Rev Allergy Immunol       Date:  2001-04       Impact factor: 8.667

3.  Multiple elements of the allergic arm of the immune response modulate autoimmune demyelination.

Authors:  Rosetta Pedotti; Jason J DeVoss; Sawsan Youssef; Dennis Mitchell; Jochen Wedemeyer; Rami Madanat; Hideki Garren; Paulo Fontoura; Mindy Tsai; Stephen J Galli; Raymond A Sobel; Lawrence Steinman
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-07       Impact factor: 11.205

Review 4.  Innate immunity in the central nervous system.

Authors:  Richard M Ransohoff; Melissa A Brown
Journal:  J Clin Invest       Date:  2012-04-02       Impact factor: 14.808

Review 5.  Mast cells and inflammation.

Authors:  Theoharis C Theoharides; Konstantinos-Dionysios Alysandratos; Asimenia Angelidou; Danae-Anastasia Delivanis; Nikolaos Sismanopoulos; Bodi Zhang; Shahrzad Asadi; Magdalini Vasiadi; Zuyi Weng; Alexandra Miniati; Dimitrios Kalogeromitros
Journal:  Biochim Biophys Acta       Date:  2010-12-23

Review 6.  The innate immune system in demyelinating disease.

Authors:  Lior Mayo; Francisco J Quintana; Howard L Weiner
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

7.  Proteinase-activated receptor-1 and -2 induce the release of chemokine GRO/CINC-1 from rat astrocytes via differential activation of JNK isoforms, evoking multiple protective pathways in brain.

Authors:  Yingfei Wang; Weibo Luo; Georg Reiser
Journal:  Biochem J       Date:  2007-01-01       Impact factor: 3.857

8.  Type I interferons attenuate T cell activating functions of human mast cells by decreasing TNF-alpha production and OX40 ligand expression while increasing IL-10 production.

Authors:  Tomoko Fujita; Naotomo Kambe; Takashi Uchiyama; Toshiyuki Hori
Journal:  J Clin Immunol       Date:  2006-09-19       Impact factor: 8.317

9.  CSF histamine contents in narcolepsy, idiopathic hypersomnia and obstructive sleep apnea syndrome.

Authors:  Takashi Kanbayashi; Tohru Kodama; Hideaki Kondo; Shinsuke Satoh; Yuichi Inoue; Shigeru Chiba; Tetsuo Shimizu; Seiji Nishino
Journal:  Sleep       Date:  2009-02       Impact factor: 5.849

10.  Tryptase is a candidate autoantigen in rheumatoid arthritis.

Authors:  Yanyan Guo; Qiao Wu; Bing Ni; Zhirong Mou; Qiong Jiang; Yi Cao; Hui Dong; Yuzhang Wu
Journal:  Immunology       Date:  2014-05       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.